Elan’s share prices continue to surge

ELAN’S share price continued to surge yesterday as the market digested news that its experimental Alzheimer’s vaccine had positive impacts on patients before it was abruptly pulled from testing after side effects emerged.

The share price was up 30% since Tuesday at the close of the Irish Stock Exchange last night.

Davy Stockbroker's analyst Jack Gorman warned that other more erratic factors, such as traders covering post the settlement of the King deal may also have been responsible for the extent of the share's price surge.